News + Filings Charts Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Xu Stella
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/02/2023 |
4
| Xu Stella (Director) has filed a Form 4 on Design Therapeutics, Inc.
Txns:
| Granted 15,000 options to buy
@ $5.63, valued at
$84.5k
|
|
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2021 |
4
| Xu Stella (Director) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns:
| Granted 6,635 options to buy
@ $11.07, valued at
$73.4k
|
|
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2021 |
4
| Xu Stella (Director) has filed a Form 4 on NextCure, Inc.
Txns:
| Granted 14,250 options to buy
@ $8.21, valued at
$117k
|
|
04/01/2021 |
4
| Xu Stella (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.
Txns:
| Converted 4,439,839 shares
@ $0 Converted 280,991 shares
@ $0 Bought 10,000 shares
@ $20, valued at
$200k
Converted 7,236,938 preferred shares
@ $0 Converted 458,016 preferred shares
@ $0 |
|
03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2020 |
4
| Xu Stella (Director) has filed a Form 4 on NextCure, Inc.
Txns:
| Granted 14,250 options to buy
@ $24.13, valued at
$343.9k
|
|
06/17/2019 |
4
| Xu Stella (Director) has filed a Form 4 on NextCure, Inc.
Txns:
| Granted 22,000 options to buy
@ $15.57, valued at
$342.5k
|
|
05/13/2019 |
4
| Xu Stella (Director) has filed a Form 4 on NextCure, Inc.
Txns:
| Converted 978,570 shares
@ $0 Bought 125,000 shares
@ $15, valued at
$1.9M
Converted 7,861,636 preferred shares
@ $0 |
|
06/22/2018 |
4
| Xu Stella (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns:
| Unknown transaction of 404,900 shares
@ $50, valued at
$20.2M
Disposed/sold 18,000 options to buy
@ $39.97, valued at
$719.5k
|
|
03/28/2018 |
4
| Xu Stella (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns:
| Granted 18,000 options to buy
@ $39.97, valued at
$719.5k
|
|
01/30/2018 |
4
| Xu Stella (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns:
| Converted 404,900 shares
@ $0 Converted 404,900 convertible preferred
@ $0 |
|
|
|